Skip to main content

Advertisement

Log in

Late infection of total knee arthroplasty inflamed by anti-TNFα, Infliximab therapy in rheumatoid arthritis

  • Case Report
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

We report a case of sudden onset of late infection after TKA inflamed by anti-TNFα therapy, Infliximab, in a 54-year-old woman with RA. Infliximab therapy was started 3 years and 8 months after TKAs as a result of multiple arthritides showing high inflammation of RA. One week after the third administration of Infliximab, the patient suffered sudden knee pain and infectious clinical symptoms, and bacteria (MSSA) were detected by joint effusion culture. She was successfully treated by open debridement with antibiotics-loaded calcium phosphate bone paste and cement and the prostheses were retained. Early diagnosis and operative treatment might be the key to controlling infected TKA without removing the implant. This present case might indicate a serious risk of immunosuppressive effects caused by Infliximab.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Abbreviations

TNFα:

Tumor necrosis factor alpha

RA:

Rheumatoid arthritis

TKA:

Total knee arthroplasty

MSSA:

Methicillin susceptible staphylococcus aureus

MTX:

Methotrexate

CRP:

C reactive protein

DAS:

Disease activity score

OA:

Osteoarthritis

References

  1. Lipsky PE, van der Heijde DM, St Clair EW et al (2000) Infliximab and methotrexate in the treatment of rheumatoid arthritis. N Engl J Med 343:1594–1602. doi:10.1056/NEJM200011303432202

    Article  CAS  PubMed  Google Scholar 

  2. Feldmann M, Maini RN (2001) Anti-TNF alpha therapy of rheumatoid arthritis: What have we learned? Annu Rev Immunol 19:163–196. doi:10.1146/annurev.immunol.19.1.163

    Article  CAS  PubMed  Google Scholar 

  3. Ellerin T, Rubin RH, Weinblatt ME (2003) Infections and anti-tumor necrosis factor α therapy. Arthritis Rheum 48:3013–3022. doi:10.1002/art.11301

    Article  CAS  PubMed  Google Scholar 

  4. van Gestel AM, Haagsma CJ, van Riel PLCM (1998) Validation of rheumatoid arthritis improvement criteria that include simplified joint counts. Arthritis Rheum 41:1845–1850. doi:10.1002/1529-0131(199810)41:10<1845::AID-ART17>3.0.CO;2-K

    Article  PubMed  Google Scholar 

  5. Keane J, Gershon S, Wise RP et al (2001) Tuberculosis associated with infliximab, a tumor necrosis factor α-neutralizing agent. N Engl J Med 345:1098–1104. doi:10.1056/NEJMoa011110

    Article  CAS  PubMed  Google Scholar 

  6. Rand JA, Bryan RS, Morrey BF et al (1986) Management of infected total knee arthroplasty. Clin Orthop Relat Res 205:75–85

    PubMed  Google Scholar 

  7. Grogan TJ, Dorey F, Rollins J et al (1986) Deep sepsis following total knee arthroplasty: ten-year experience at the University of California at Los Angels Medical Center. J Bone Joint Surg Am 68:226–234

    CAS  PubMed  Google Scholar 

  8. Bengtson S, Knutson K (1991) The infected knee arthroplasty: a 6-year follow-up of 357 cases. Acta Orthop Scand 62:301–311

    Article  CAS  PubMed  Google Scholar 

  9. Wilson MG, Kelley K, Thornhill TS (1990) Infection as a complication of total knee-replacement arthroplasty: risk factors and treatment in sixty-seven cases. J Bone Joint Surg Am 72:878–883

    CAS  PubMed  Google Scholar 

  10. Segawa H, Tsukayama DT, Kyle RF et al (1999) Infection after total knee arthroplasty: a retrospective study of the treatment of eighty-one infections. J Bone Joint Surg Am 81:1434–1445

    CAS  PubMed  Google Scholar 

  11. Deirmengian C, Greenbaum J, Stern J et al (2003) Open debridement of acute gram-positive infections after total knee arthroplasty. Clin Orthop Relat Res 416:129–134. doi:10.1097/01.blo.0000092996.90435.35

    Article  PubMed  Google Scholar 

  12. Brandt CM, Sistrunk WW, Duffy MC et al (1997) Staphylococcus aureus prosthetic joint infection treated with debridement and prosthesis retention. Clin Infect Dis 24:914–919

    CAS  PubMed  Google Scholar 

  13. Tattevin P, Crémieux AC, Pottier P et al (1999) Prosthetic joint infection: when can prosthesis salvage be considered? Clin Infect Dis 29:292–295. doi:10.1086/520202

    Article  CAS  PubMed  Google Scholar 

  14. Sasaki S, Ishii Y (1999) Apatite cement containing antibiotics: efficacy in treating experimental osteomyelitis. J Orthop Sci 4:361–369. doi:10.1007/s007760050117

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

Informed consent for the publication of data concerning this case was received from the patient. The authors thank the patient for her permission to use her case to highlight the issues noted in this article and to use her radiographs to demonstrate these issues. Additionally the authors thank Ms. Tubby for her help in preparing the manuscript.

Conflict of interest statement

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Takashi Yurube.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yurube, T., Takahi, K., Owaki, H. et al. Late infection of total knee arthroplasty inflamed by anti-TNFα, Infliximab therapy in rheumatoid arthritis. Rheumatol Int 30, 405–408 (2010). https://doi.org/10.1007/s00296-009-0948-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-009-0948-x

Keywords

Navigation